Mutual of America Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.07M Sell
38,461
-3,034
-7% -$403K 0.06% 393
2025
Q4
$5.89M Sell
41,495
-4,311
-9% -$625K 0.06% 366
2025
Q3
$6.43M Sell
45,806
-3,411
-7% -$462K 0.07% 343
2025
Q2
$6.19M Sell
49,217
-2,100
-4% -$241K 0.07% 336
2025
Q1
$5.68M Sell
51,317
-2,165
-4% -$274K 0.07% 363
2024
Q4
$7.3M Sell
53,482
-1,091
-2% -$135K 0.08% 285
2024
Q3
$6.29M Sell
54,573
-3,048
-5% -$418K 0.07% 364
2024
Q2
$7.93M Sell
57,621
-1,669
-3% -$229K 0.09% 234
2024
Q1
$8.18M Sell
59,290
-1,391
-2% -$190K 0.09% 237
2023
Q4
$8M Sell
60,681
-2,774
-4% -$319K 0.09% 221
2023
Q3
$7.14M Sell
63,455
-7,237
-10% -$762K 0.09% 231
2023
Q2
$6.67M Sell
70,692
-6,997
-9% -$684K 0.08% 291
2023
Q1
$7.86M Sell
77,689
-1,263
-2% -$131K 0.09% 224
2022
Q4
$9.43M Buy
78,952
+2,126
+3% +$249K 0.12% 173
2022
Q3
$8.16M Sell
76,826
-3,080
-4% -$313K 0.11% 188
2022
Q2
$7.79M Sell
79,906
-6,598
-8% -$609K 0.1% 230
2022
Q1
$8.11M Buy
86,504
+1,672
+2% +$142K 0.09% 286
2021
Q4
$7.22M Buy
84,832
+1,402
+2% +$129K 0.07% 364
2021
Q3
$8M Buy
83,430
+224
+0.3% +$21.2K 0.08% 285
2021
Q2
$8.1M Sell
83,206
-1,166
-1% -$112K 0.08% 298
2021
Q1
$8.21M Buy
+84,372
New +$8.85M 0.09% 279
2020
Q4
Sell
-1,195
Closed -$115K 1678
2020
Q3
$115K Hold
1,195
﹤0.01% 1363
2020
Q2
$146K Sell
1,195
-15,532
-93% -$1.72M ﹤0.01% 1149
2020
Q1
$1.45M Sell
16,727
-8,854
-35% -$867K 0.02% 852
2019
Q4
$2.75M Sell
25,581
-350
-1% -$36.6K 0.04% 770
2019
Q3
$2.34M Sell
25,931
-137
-0.5% -$12.8K 0.03% 789
2019
Q2
$2.2M Sell
26,068
-7,793
-23% -$640K 0.03% 837
2019
Q1
$2.98M Sell
33,861
-13,983
-29% -$1.17M 0.04% 666
2018
Q4
$3.42M Sell
47,844
-19,204
-29% -$1.84M 0.06% 530
2018
Q3
$8.24M Sell
67,048
-40,326
-38% -$4.58M 0.12% 187
2018
Q2
$10.5M Sell
107,374
-133
-0.1% -$11.9K 0.16% 110
2018
Q1
$8.92M Sell
107,507
-146
-0.1% -$12.3K 0.14% 136
2017
Q4
$8.35M Sell
107,653
-5,209
-5% -$355K 0.13% 163
2017
Q3
$6.92M Buy
112,862
+1,036
+0.9% +$54.7K 0.11% 210
2017
Q2
$5.14M Buy
111,826
+40,694
+57% +$1.97M 0.09% 326
2017
Q1
$3.08M Sell
71,132
-1,442
-2% -$61.8K 0.05% 583
2016
Q4
$2.81M Buy
72,574
+670
+0.9% +$30.3K 0.05% 600
2016
Q3
$3.64M Hold
71,904
0.07% 439
2016
Q2
$3.27M Buy
71,904
+200
+0.3% +$9.21K 0.07% 441
2016
Q1
$2.84M Sell
71,704
-300
-0.4% -$11.9K 0.06% 482
2015
Q4
$4.07M Buy
72,004
+427
+0.6% +$21.7K 0.09% 289
2015
Q3
$2.85M Buy
71,577
+20,950
+41% +$1.01M 0.07% 443
2015
Q2
$2.42M Buy
50,627
+1,050
+2% +$44.5K 0.05% 614
2015
Q1
$1.97M Buy
+49,577
New +$1.77M 0.04% 729

Other funds holding NBIX